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Background: Hypertrophic cardiomyopathy (HCM) is the most common, heritable cardiovascular disorder and the most frequent cause of sudden 
cardiac death (SCD) in young adults. Gender disparities with regards to clinical outcomes among HCM patients are not well-defined. We investigated 
the relationship between gender and cardiovascular outcomes within a large population of HCM patients.
Methods: Cine and late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMR) were performed on HCM patients from a 
multi-center, international cohort. CMR scans were analyzed at a single data coordinating center. Primary outcome was a composite end-point 
of major adverse cardiovascular events which included SCD, aborted cardiac arrest, appropriate implantable cardioverter-defibrillator shock for 
ventricular tachycardia/fibrillation, cardiac transplant, progressive heart failure symptoms to NYHA class III or IV, embolic stroke death, or heart 
failure death.
Results: Among our cohort of 594 HCM patients (age, 49±16 y), 35% were women. Women were slightly older than men (51±17 vs. 48±16 y, 
p=0.02), but had smaller maximal left ventricular (LV) wall thickness (19.2±4.8 vs. 20.3±5.6 mm, p<0.02). There was no difference in LV ejection 
fraction (67±10% vs. 66±9%, p>0.10) or the presence or extent (% LV mass) of LGE (38% vs. 44%, p=0.22; 10.8±12.3% vs. 10.1±10.8% when LGE 
present, p=0.66). Over a follow-up of 3.5±1.4 y, the primary outcome occurred in 73 patients (12.3%), including 33 (16%) women and 40 (10%) 
men. Multivariable analysis revealed that female gender was independently associated with an increased risk of the primary end-point (Adjusted 
OR=1.9, 95% CI [1.12, 3.17], p=0.02), even after controlling for clinical variables (age, resting LV outflow tract gradient >30 mm Hg, LV ejection 
fraction) and SCD risk factors (LV mass, LGE, maximal LV wall thickness, unexplained syncope, family history of SCD due to HCM, and ambulatory 
non-sustained ventricular tachycardia).
Conclusion: In this multi-center, international cohort of HCM patients with CMR testing, female gender was associated with HCM-related adverse 
cardiovascular events.
